scholarly journals An inducible mouse model of podocin-mutation-related nephrotic syndrome

PLoS ONE ◽  
2017 ◽  
Vol 12 (10) ◽  
pp. e0186574 ◽  
Author(s):  
Mansoureh Tabatabaeifar ◽  
Tanja Wlodkowski ◽  
Ivana Simic ◽  
Helga Denc ◽  
Geraldine Mollet ◽  
...  
2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Keisuke Teramoto ◽  
Yu Tsurekawa ◽  
Mary Ann Suico ◽  
Shota Kaseda ◽  
Kohei Omachi ◽  
...  

Abstract Nephrotic syndrome (NS) is a renal disorder that is characterized by massive proteinuria, hypoalbuminemia and edema. One of the main causes of NS is focal segmental glomerulosclerosis (FSGS), which has extremely poor prognosis. Although steroids and immunosuppressants are the first line of treatment, some FSGS cases are refractory, prompting the need to find new therapeutic strategies. We have previously demonstrated that an optimized combination treatment of mild electrical stimulation (MES) and heat shock (HS) has several biological benefits including the amelioration of the pathologies of the genetic renal disorder Alport syndrome. Here, we investigated the effect of MES + HS on adriamycin (ADR)-induced NS mouse model. MES + HS suppressed proteinuria and glomerulosclerosis induced by ADR. The expressions of pro-inflammatory cytokines and pro-fibrotic genes were also significantly downregulated by MES + HS. MES + HS decreased the expression level of cleaved caspase-3 and the number of TUNEL-positive cells, indicating that MES + HS exerted anti-apoptotic effect. Moreover, MES + HS activated the Akt signaling and induced the phosphorylation and inhibition of the apoptotic molecule BAD. In in vitro experiment, the Akt inhibitor abolished the MES + HS-induced Akt-BAD signaling and anti-apoptotic effect in ADR-treated cells. Collectively, our study suggested that MES + HS modulates ADR-induced pathologies and has renoprotective effect against ADR-induced NS via regulation of Akt-BAD axis.


2020 ◽  
Vol 231 (1) ◽  
Author(s):  
Mengyun Xiao ◽  
Bernhard N. Bohnert ◽  
Hande Aypek ◽  
Oliver Kretz ◽  
Florian Grahammer ◽  
...  

2007 ◽  
Vol 18 (10) ◽  
pp. 2732-2739 ◽  
Author(s):  
Anne-Laure Sellier-Leclerc ◽  
Arnaud Duval ◽  
Stéphanie Riveron ◽  
Marie-Alice Macher ◽  
Georges Deschenes ◽  
...  

2020 ◽  
Vol 98 (1) ◽  
pp. 133-146 ◽  
Author(s):  
Steven D. Funk ◽  
Raymond H. Bayer ◽  
Karen K. McKee ◽  
Kazushi Okada ◽  
Hiroshi Nishimune ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-12 ◽  
Author(s):  
Chao-Wen Cheng ◽  
Wen-Liang Chang ◽  
Li-Cheng Chang ◽  
Chia-Chao Wu ◽  
Yuh-Feng Lin ◽  
...  

Membranous nephropathy (MN) is a leading cause of adult nephrotic syndrome but lacks adequate treatment. Different extracts ofAngelica sinensis(AS) and one of its active compounds, ferulic acid (FA), were used to evaluate the therapeutic effects in a MN mouse model. The MN model was grouped into three subgroups: no treatment (N-T), treatment at induction of MN (Pre-T), and treatment after full-blown MN (Post-T). The results showed that the methanol (ME) layer of AS extract exhibited a therapeutic effect on MN-induced proteinuria. The ME layer-enriched compound, FA, improved the hypoalbuminemia, hyperlipidemia, and proteinuria in both Pre-T and Post-T groups. Ferulic acid also reduced the formation of oxidative protein products and increased the synthesis of antioxidant enzymes in groups Pre-T and Post-T. Regarding angiogenesis factors, the antiangiogenic factors in renal glomeruli were increased in group N-T, but, after FA treatment, only one of the antiangiogenic factors, thrombospondin-1, showed a significant decrease. Furthermore, the expression of Th2 predominant showed significant decrease in both Pre-T and Post-T groups when compared to that of N-T group. In summary, FA retarded the progression of MN, and the mechanisms involved the regulation of oxidative stresses, angiogenic and antiangiogenic factors, and attenuation of Th2 response.


Nephron ◽  
1994 ◽  
Vol 68 (2) ◽  
pp. 239-244 ◽  
Author(s):  
Atsuo Ogura ◽  
Toshihiko Asano ◽  
Osamu Suzuki ◽  
Yoshie Yamamoto ◽  
Yoko Noguchi ◽  
...  

2011 ◽  
Vol 187 (6) ◽  
pp. 3218-3229 ◽  
Author(s):  
Catherine Meyer-Schwesinger ◽  
Silke Dehde ◽  
Philipp Klug ◽  
Jan U. Becker ◽  
Sabrina Mathey ◽  
...  

Cell ◽  
1990 ◽  
Vol 62 (3) ◽  
pp. 425-434 ◽  
Author(s):  
Hans Weiher ◽  
Tetsuo Noda ◽  
Douglas A. Gray ◽  
Arlene H. Sharpe ◽  
Rudolf Jaenisch

Cells ◽  
2021 ◽  
Vol 10 (6) ◽  
pp. 1509
Author(s):  
Jasmin I. Maier ◽  
Manuel Rogg ◽  
Martin Helmstädter ◽  
Alena Sammarco ◽  
Gerd Walz ◽  
...  

Glomerular kidney disease causing nephrotic syndrome is a complex systemic disorder and is associated with significant morbidity in affected patient populations. Despite its clinical relevance, well-established models are largely missing to further elucidate the implications of uncontrolled urinary protein loss. To overcome this limitation, we generated a novel, inducible, podocyte-specific transgenic mouse model (Epb41l5fl/fl*Nphs1-rtTA-3G*tetOCre), developing nephrotic syndrome in adult mice. Animals were comprehensively characterized, including microbiome analysis and multiplexed immunofluorescence imaging. Induced knockout mice developed a phenotype consistent with focal segmental glomerular sclerosis (FSGS). Although these mice showed hallmark features of severe nephrotic syndrome (including proteinuria, hypoalbuminemia and dyslipidemia), they did not exhibit overt chronic kidney disease (CKD) phenotypes. Analysis of the gut microbiome demonstrated distinct dysbiosis and highly significant enrichment of the Alistipes genus. Moreover, Epb41l5-deficient mice developed marked organ pathologies, including extramedullary hematopoiesis of the spleen. Multiplex immunofluorescence imaging demonstrated red pulp macrophage proliferation and mTOR activation as driving factors of hematopoietic niche expansion. Thus, this novel mouse model for adult-onset nephrotic syndrome reveals the significant impact of proteinuria on extra-renal manifestations, demonstrating the versatility of this model for nephrotic syndrome-related research.


Sign in / Sign up

Export Citation Format

Share Document